Zobrazeno 1 - 10
of 30
pro vyhledávání: '"H C, Standiford"'
Autor:
E. L. Heil, H. C. Standiford
Publikováno v:
Antimicrobial stewardship: principles and practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43acce711cd7f44d63f7d0f093259c90
https://doi.org/10.1079/9781780644394.0284
https://doi.org/10.1079/9781780644394.0284
Autor:
H C Standiford, A C Reboli, C G Mayhall, Maury Ellis Mulligan, Matthew Bidwell Goetz, T J Walsh, B S Ribner, J Z Montgomerie, David Rimland, Joseph F. John
Publikováno v:
Antimicrobial Agents and Chemotherapy. 37:1334-1342
Methicillin-resistant Staphylococcus aureus (MRSA) is a major pathogen in hospitals. Current antimicrobial regimens for eradicating colonizing strains are not well defined and are often complicated by the emergence of resistance. The combination of n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea6fdf1b0df436de7b04e6e9d3ad368a
https://doi.org/10.1128/aac.37.6.1334
https://doi.org/10.1128/aac.37.6.1334
Publikováno v:
Antimicrobial Agents and Chemotherapy. 37:483-490
We examined the impact of dose fractionation and altered MICs on survivorship in a neutropenic rat model of Pseudomonas aeruginosa sepsis employing the new fluoroquinolone antibiotic lomefloxacin. Once-daily administration of a drug dose which produc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8767c7a5935ff228fc04d592d467c8f
https://doi.org/10.1128/aac.37.3.483
https://doi.org/10.1128/aac.37.3.483
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 22(4)
To evaluate the effectiveness of low-dose oral alpha-interferon (alpha-IFN), 247 HIV-infected study subjects received placebo, Alferon LDO, Veldona, or Ferimmune in a randomized, double-blind trial. Subjects had CD4+ counts between 50 and 350 cells/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8374c8c6cd193f37b37020500f79b9f9
https://pubmed.ncbi.nlm.nih.gov/10634196
https://pubmed.ncbi.nlm.nih.gov/10634196
Publikováno v:
The Journal of infectious diseases. 178(1)
A multicenter, double-blind, placebo-controlled trial randomized 28 patients with primary (acute) human immunodeficiency virus (HIV)-1 infection (PHI) to receive zidovudine, 1000 mg daily, or placebo for 24 weeks. At week 48, compared with placebo pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::988d3c200c1729176cf177bb96f4b702
https://pubmed.ncbi.nlm.nih.gov/9652426
https://pubmed.ncbi.nlm.nih.gov/9652426
We studied the impact of zidovudine (AZT) in Cas-Br-M murine leukemia virus-infected NFS-N mice after administration by once-daily bolus or continuous infusion. While higher peak concentrations of AZT were achieved by once-daily dosing, continuous AZ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e772c66fc5660d8384ba6ea51dee40d
https://europepmc.org/articles/PMC284511/
https://europepmc.org/articles/PMC284511/
Publikováno v:
Clinical pharmacology and therapeutics. 48(2)
The epidemic of human immunodeficiency virus infection has forced an unprecedented acceleration of drug development. The lack of effective therapy at present against many of the infectious complications of acquired immunodeficiency syndrome (AIDS) ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9fefa12857bb4c0705d1413559d46a40
https://pubmed.ncbi.nlm.nih.gov/2199132
https://pubmed.ncbi.nlm.nih.gov/2199132
Autor:
Stephen C. Schimpff, Beverly A. Tatem, H C Standiford, V M Young, William H. Greene, Richard B. Hornick, Ronica M. Kluge, Frank M. Calia
Publikováno v:
Antimicrobial Agents and Chemotherapy. 6:442-446
The effect of gentamicin against 130 clinical isolates of Pseudomonas aeruginosa was compared with that of two investigational aminoglycoside antibiotics, tobramycin and amikacin. Minimal inhibitory concentration data indicated that, on a weight basi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2f6c898b691d57ebf2f8f1e08494d4a
https://doi.org/10.1128/aac.6.4.442
https://doi.org/10.1128/aac.6.4.442
Publikováno v:
Journal of Antimicrobial Chemotherapy. 14:491-497
We determined the serum bactericidal activity 1 h after the end of 2 g, 30 min infusions of latamoxef, cefoperazone and cefotaxime in six volunteers against six strains each of Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus and Pseudo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::654fdd4b241b6bce7df9f8eac4a2911b
https://doi.org/10.1093/jac/14.5.491
https://doi.org/10.1093/jac/14.5.491
Publikováno v:
Antimicrobial Agents and Chemotherapy. 26:678-682
Imipenem (formerly N-formimidoyl thienamycin) and ceftazidime were investigated for their postantibiotic effect on Pseudomonas aeruginosa. Four strains of P. aeruginosa in the logarithmic phase of growth were exposed for 1 and 2 h to concentrations o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a655c7a7d116b229485084b2093b51bf
https://doi.org/10.1128/aac.26.5.678
https://doi.org/10.1128/aac.26.5.678